The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non-Sterile Compounding Pharmacy-Global Market Insights and Sales Trends 2024
Synopsis
Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible.
The global Non-Sterile Compounding Pharmacy market size is expected to reach US$ 725 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Non-Sterile Compounding Pharmacy in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Non-Sterile Compounding Pharmacy market. Oral Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Topical Medications segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Sterile Compounding Pharmacy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Sterile Compounding Pharmacy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Sterile Compounding Pharmacy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Sterile Compounding Pharmacy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Sterile Compounding Pharmacy covered in this report include Fagron, B.Braun Melsungen, Fresenius Kabi, True Nature Holding, Dougherty's Pharmacy and Pharmedium, etc.
The global Non-Sterile Compounding Pharmacy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fagron
B.Braun Melsungen
Fresenius Kabi
True Nature Holding
Dougherty's Pharmacy
Pharmedium
Global Non-Sterile Compounding Pharmacy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Sterile Compounding Pharmacy market, Segment by Type:
Oral Medication
Topical Medications
Otologic/Nasal Medication
Global Non-Sterile Compounding Pharmacy market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Sterile Compounding Pharmacy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible.
The global Non-Sterile Compounding Pharmacy market size is expected to reach US$ 725 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Non-Sterile Compounding Pharmacy in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Non-Sterile Compounding Pharmacy market. Oral Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Topical Medications segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Sterile Compounding Pharmacy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Sterile Compounding Pharmacy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Sterile Compounding Pharmacy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Sterile Compounding Pharmacy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Sterile Compounding Pharmacy covered in this report include Fagron, B.Braun Melsungen, Fresenius Kabi, True Nature Holding, Dougherty's Pharmacy and Pharmedium, etc.
The global Non-Sterile Compounding Pharmacy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fagron
B.Braun Melsungen
Fresenius Kabi
True Nature Holding
Dougherty's Pharmacy
Pharmedium
Global Non-Sterile Compounding Pharmacy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Sterile Compounding Pharmacy market, Segment by Type:
Oral Medication
Topical Medications
Otologic/Nasal Medication
Global Non-Sterile Compounding Pharmacy market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Sterile Compounding Pharmacy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Non-Sterile Compounding Pharmacy
1.1 Non-Sterile Compounding Pharmacy Market Overview
1.1.1 Non-Sterile Compounding Pharmacy Product Scope
1.1.2 Non-Sterile Compounding Pharmacy Market Status and Outlook
1.2 Global Non-Sterile Compounding Pharmacy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Non-Sterile Compounding Pharmacy Market Size by Region (2018-2029)
1.4 Global Non-Sterile Compounding Pharmacy Historic Market Size by Region (2018-2023)
1.5 Global Non-Sterile Compounding Pharmacy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Non-Sterile Compounding Pharmacy Market Size (2018-2029)
1.6.1 North America Non-Sterile Compounding Pharmacy Market Size (2018-2029)
1.6.2 Europe Non-Sterile Compounding Pharmacy Market Size (2018-2029)
1.6.3 Asia-Pacific Non-Sterile Compounding Pharmacy Market Size (2018-2029)
1.6.4 Latin America Non-Sterile Compounding Pharmacy Market Size (2018-2029)
1.6.5 Middle East & Africa Non-Sterile Compounding Pharmacy Market Size (2018-2029)
2 Non-Sterile Compounding Pharmacy Market by Type
2.1 Introduction
2.1.1 Oral Medication
2.1.2 Topical Medications
2.1.3 Otologic/Nasal Medication
2.2 Global Non-Sterile Compounding Pharmacy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Non-Sterile Compounding Pharmacy Historic Market Size by Type (2018-2023)
2.2.2 Global Non-Sterile Compounding Pharmacy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Non-Sterile Compounding Pharmacy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Non-Sterile Compounding Pharmacy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Non-Sterile Compounding Pharmacy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Non-Sterile Compounding Pharmacy Revenue Breakdown by Type (2018-2029)
3 Non-Sterile Compounding Pharmacy Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Non-Sterile Compounding Pharmacy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Non-Sterile Compounding Pharmacy Historic Market Size by Application (2018-2023)
3.2.2 Global Non-Sterile Compounding Pharmacy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Non-Sterile Compounding Pharmacy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Non-Sterile Compounding Pharmacy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Non-Sterile Compounding Pharmacy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Non-Sterile Compounding Pharmacy Revenue Breakdown by Application (2018-2029)
4 Non-Sterile Compounding Pharmacy Competition Analysis by Players
4.1 Global Non-Sterile Compounding Pharmacy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Sterile Compounding Pharmacy as of 2022)
4.3 Date of Key Players Enter into Non-Sterile Compounding Pharmacy Market
4.4 Global Top Players Non-Sterile Compounding Pharmacy Headquarters and Area Served
4.5 Key Players Non-Sterile Compounding Pharmacy Product Solution and Service
4.6 Competitive Status
4.6.1 Non-Sterile Compounding Pharmacy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Fagron
5.1.1 Fagron Profile
5.1.2 Fagron Main Business
5.1.3 Fagron Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.1.4 Fagron Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.1.5 Fagron Recent Developments
5.2 B.Braun Melsungen
5.2.1 B.Braun Melsungen Profile
5.2.2 B.Braun Melsungen Main Business
5.2.3 B.Braun Melsungen Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.2.4 B.Braun Melsungen Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.2.5 B.Braun Melsungen Recent Developments
5.3 Fresenius Kabi
5.3.1 Fresenius Kabi Profile
5.3.2 Fresenius Kabi Main Business
5.3.3 Fresenius Kabi Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.3.4 Fresenius Kabi Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.3.5 True Nature Holding Recent Developments
5.4 True Nature Holding
5.4.1 True Nature Holding Profile
5.4.2 True Nature Holding Main Business
5.4.3 True Nature Holding Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.4.4 True Nature Holding Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.4.5 True Nature Holding Recent Developments
5.5 Dougherty's Pharmacy
5.5.1 Dougherty's Pharmacy Profile
5.5.2 Dougherty's Pharmacy Main Business
5.5.3 Dougherty's Pharmacy Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.5.4 Dougherty's Pharmacy Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.5.5 Dougherty's Pharmacy Recent Developments
5.6 Pharmedium
5.6.1 Pharmedium Profile
5.6.2 Pharmedium Main Business
5.6.3 Pharmedium Non-Sterile Compounding Pharmacy Products, Services and Solutions
5.6.4 Pharmedium Non-Sterile Compounding Pharmacy Revenue (US$ Million) & (2018-2023)
5.6.5 Pharmedium Recent Developments
6 North America
6.1 North America Non-Sterile Compounding Pharmacy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Non-Sterile Compounding Pharmacy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Non-Sterile Compounding Pharmacy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Non-Sterile Compounding Pharmacy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Non-Sterile Compounding Pharmacy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Non-Sterile Compounding Pharmacy Market Dynamics
11.1 Non-Sterile Compounding Pharmacy Industry Trends
11.2 Non-Sterile Compounding Pharmacy Market Drivers
11.3 Non-Sterile Compounding Pharmacy Market Challenges
11.4 Non-Sterile Compounding Pharmacy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
